Armata Pharmaceuticals (ARMP) Preferred Dividend Payments (2013 - 2016)
Armata Pharmaceuticals' (ARMP) quarterly Preferred Dividend Payments came in at $133000.0 in Q2 2016, down 92.72% year-on-year from $1.8 million in Q3 2015, and down 92.29% quarter-over-quarter from $1.7 million in Q1 2016.
Armata Pharmaceuticals (ARMP) Preferred Dividend Payments (2013 - 2016) Analysis & Trends
Armata Pharmaceuticals has disclosed Preferred Dividend Payments across 4 years of filings, most recently posting $133000.0 for Q2 2016.
- Preferred Dividend Payments for Q2 2016 came in at $133000.0, down 92.72% year-over-year; the trailing twelve-month figure through Dec 2016 was $1.9 million (down 81.92% YoY), and the FY2016 annual result was $1.9 million, down 81.92% from the prior year.
- Preferred Dividend Payments came in at $133000.0 for Q2 2016 at Armata Pharmaceuticals, down from $1.7 million in the prior quarter.
- In the past five years, Preferred Dividend Payments ranged from a high of $7.2 million in Q3 2015 to a low of $103000.0 in Q2 2013.
- The 4-year median for Preferred Dividend Payments is $323000.0 (2014), against an average of $1.1 million.
- Across the five-year window, Preferred Dividend Payments soared 2117.65% in 2015 and sank 92.72% in 2016, its largest moves.
- Armata Pharmaceuticals' Preferred Dividend Payments stood at $229000.0 in 2013, then jumped by 44.1% to $330000.0 in 2014, then jumped by 187.58% to $949000.0 in 2015, then plunged by 85.99% to $133000.0 in 2016.
- The last three Preferred Dividend Payments figures came in at $133000.0 (Q2 2016), $1.7 million (Q1 2016), and $949000.0 (Q4 2015), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Armata Pharmaceuticals | 275.44 Mn | 270.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2016 | 133,000.00 |
| Mar 31, 2016 | 1.73 Mn |
| Dec 31, 2015 | 949,000.00 |
| Sep 30, 2015 | 7.16 Mn |
| Jun 30, 2015 | 1.83 Mn |
| Mar 31, 2015 | 338,000.00 |
| Dec 31, 2014 | 330,000.00 |
| Sep 30, 2014 | 323,000.00 |
| Jun 30, 2014 | 318,000.00 |
| Mar 31, 2014 | 314,000.00 |
| Dec 31, 2013 | 229,000.00 |
| Sep 30, 2013 | 286,000.00 |
| Jun 30, 2013 | 103,000.00 |